Literature DB >> 2473310

Effect of endothelin-1 on arterioles and venules in vivo.

Z B Fortes1, G de Nucci, J Garcia-Leme.   

Abstract

The vasoconstrictor effects of endothelin-1 (ET-1) and norepinephrine (NE) were compared in the exteriorized rat mesentery in situ. ET-1 was 1,000 times more potent than NE in constricting both arterioles and venules. Vasoconstrictions induced by ET-1 lasted much longer than those caused by the catecholamine. At nonrelaxant doses, acetylcholine and sodium nitroprusside antagonized the constrictive response of microvessels to ET-1 and NE. However, larger doses of acetylcholine were necessary to inhibit the response to ET-1 than that to NE.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2473310     DOI: 10.1097/00005344-198900135-00056

Source DB:  PubMed          Journal:  J Cardiovasc Pharmacol        ISSN: 0160-2446            Impact factor:   3.105


  5 in total

1.  Simultaneous perfusion of rat isolated superior mesenteric arterial and venous beds: comparison of their vasoconstrictor and vasodilator responses to agonists.

Authors:  T D Warner
Journal:  Br J Pharmacol       Date:  1990-02       Impact factor: 8.739

2.  Activities of endothelin-1 in the vascular network of the rabbit ear: a microangiographic study.

Authors:  M D Randall; D H Edwards; T M Griffith
Journal:  Br J Pharmacol       Date:  1990-12       Impact factor: 8.739

3.  Altered microvascular reactivity to endothelin-1, endothelin-3 and NG-nitro-L-arginine methyl ester in streptozotocin-induced diabetes mellitus.

Authors:  E Lawrence; S D Brain
Journal:  Br J Pharmacol       Date:  1992-08       Impact factor: 8.739

4.  Responses to endothelins in the rat cutaneous microvasculature: a modulatory role of locally-produced nitric oxide.

Authors:  E Lawrence; S D Brain
Journal:  Br J Pharmacol       Date:  1992-07       Impact factor: 8.739

5.  Endothelin-1 inhibits PAF-induced paw oedema and pleurisy in the mouse.

Authors:  M G Henriques; G A Rae; R S Cordeiro; T J Williams
Journal:  Br J Pharmacol       Date:  1992-07       Impact factor: 8.739

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.